Immunotherapies in Bladder Cancer Treatment: Expert Insights and Strategies

Table of Contents

 
  • Program Overview
    Immunotherapies in Bladder Cancer Treatment: Expert Insights and Strategies
    Get patient-specific treatment recommendations from experts with our Interactive Treatment Decision Support Tool. Review the data behind these recommendations in our CME/CE-certified virtual presentation with downloadable slides as well as short commentaries developed by the experts for the optimal use of immunotherapies for bladder cancer!
  • Featured content
    The evolution of immune checkpoint inhibitors for advanced bladder cancer may eventually replace chemotherapy. Read my thoughts on these new agents and how I use them in the clinic.
    Date Posted: 12/14/2017
  • 1
  • 2

Latest Content

3 of 3 Shown
  • Advanced Bladder Cancer Treatment: Patient-Specific Expert Insights and Strategies

    This Interactive Decision Support Tool will let you compare your choice of therapy for patients with advanced bladder cancer with expert recommendations from Matthew Galsky, MD; Matthew I. Milowsky, MD; Daniel P. Petrylak, MD; Elizabeth R. Plimack, MD, MS; and Jonathan E. Rosenberg, MD.
    Date Posted: 2/8/2018
  • Beyond Chemotherapy: Checkpoint Inhibitors Are Changing My Approach to Bladder Cancer

    Matthew Galsky MD - 12/14/2017
    The evolution of immune checkpoint inhibitors for advanced bladder cancer may eventually replace chemotherapy. Read my thoughts on these new agents and how I use them in the clinic.
  • How I Manage Patients With Locally Advanced, Unresectable Bladder Cancer

    Elizabeth R. Plimack MD, MS - 12/1/2017 2 comments / Last Comment: 12/29/2017
    Best practices for treating unresectable, locally advanced bladder cancer continue to evolve. Read my thoughts on tailoring treatment based on specific patient and disease characteristics in this setting.
3 of 3 Shown
Show 0 More
Loading...